Logo image of NCBS

NICOLET BANKSHARES INC (NCBS) Stock Fundamental Analysis

USA - NASDAQ:NCBS - US65406E1029 - Common Stock

78.01
+2.66 (+3.53%)
Last: 5/23/2022, 8:00:02 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to NCBS. NCBS was compared to 390 industry peers in the Banks industry. NCBS has a bad profitability rating. Also its financial health evaluation is rather negative. NCBS is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NCBS was profitable.
NCBS Yearly Net Income VS EBIT VS OCF VS FCFNCBS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 20M 40M 60M 80M

1.2 Ratios

Industry RankSector Rank
ROA 0.91%
ROE 7.96%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NCBS Yearly ROA, ROE, ROICNCBS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2 4 6 8 10

1.3 Margins

The Operating Margin and Gross Margin are not available for NCBS so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 27.25%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NCBS Yearly Profit, Operating, Gross MarginsNCBS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 10 20 30

More info and screens

0

2. Health

2.1 Basic Checks

NCBS has more shares outstanding than it did 1 year ago.
The debt/assets ratio for NCBS is higher compared to a year ago.
NCBS Yearly Shares OutstandingNCBS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M
NCBS Yearly Total Debt VS Total AssetsNCBS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2B 4B 6B

2.2 Solvency

NCBS has a Debt/Equity ratio of 0.23. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACCN/A
NCBS Yearly LT Debt VS Equity VS FCFNCBS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 200M 400M 600M 800M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

More info and screens

8

3. Growth

3.1 Past

The earnings per share for NCBS have decreased strongly by -16.02% in the last year.
NCBS shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 17.36% yearly.
Looking at the last year, NCBS shows a very strong growth in Revenue. The Revenue has grown by 21.00%.
NCBS shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 18.91% yearly.
EPS 1Y (TTM)-16.02%
EPS 3Y10.11%
EPS 5Y17.36%
EPS Q2Q%-2.86%
Revenue 1Y (TTM)21%
Revenue growth 3Y15.55%
Revenue growth 5Y18.91%
Sales Q2Q%37.36%

3.2 Future

Based on estimates for the next years, NCBS will show a very strong growth in Earnings Per Share. The EPS will grow by 21.67% on average per year.
NCBS is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 35.03% yearly.
EPS Next Y32.09%
EPS Next 2Y22.64%
EPS Next 3Y21.59%
EPS Next 5Y21.67%
Revenue Next Year57.51%
Revenue Next 2Y34.89%
Revenue Next 3Y34.54%
Revenue Next 5Y35.03%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NCBS Yearly Revenue VS EstimatesNCBS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
NCBS Yearly EPS VS EstimatesNCBS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

NCBS is valuated correctly with a Price/Earnings ratio of 14.31.
NCBS is valuated rather cheaply when we compare the Price/Earnings ratio to 26.11, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.43, the valuation of NCBS can be described as very reasonable.
The average S&P500 Price/Forward Earnings ratio is at 22.55. NCBS is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 14.31
Fwd PE 9.43
NCBS Price Earnings VS Forward Price EarningsNCBS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NCBS Per share dataNCBS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

NCBS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as NCBS's earnings are expected to grow with 21.59% in the coming years.
PEG (NY)0.45
PEG (5Y)0.82
EPS Next 2Y22.64%
EPS Next 3Y21.59%

More info and screens

0

5. Dividend

5.1 Amount

NCBS does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NICOLET BANKSHARES INC

NASDAQ:NCBS (5/23/2022, 8:00:02 PM)

78.01

+2.66 (+3.53%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)04-19 2022-04-19/amc
Earnings (Next)07-18 2022-07-18
Inst Owners51.76%
Inst Owner Change0.06%
Ins Owners4.18%
Ins Owner Change0%
Market Cap1.04B
Revenue(TTM)244.29M
Net Income(TTM)66.57M
Analysts81.82
Price Target110.16 (41.21%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 14.31
Fwd PE 9.43
P/S 4.28
P/FCF N/A
P/OCF N/A
P/B 1.25
P/tB N/A
EV/EBITDA N/A
EPS(TTM)5.45
EY6.99%
EPS(NY)8.27
Fwd EY10.6%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS18.24
BVpS62.45
TBVpSN/A
PEG (NY)0.45
PEG (5Y)0.82
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 0.91%
ROE 7.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 27.25%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.02%
EPS 3Y10.11%
EPS 5Y17.36%
EPS Q2Q%-2.86%
EPS Next Y32.09%
EPS Next 2Y22.64%
EPS Next 3Y21.59%
EPS Next 5Y21.67%
Revenue 1Y (TTM)21%
Revenue growth 3Y15.55%
Revenue growth 5Y18.91%
Sales Q2Q%37.36%
Revenue Next Year57.51%
Revenue Next 2Y34.89%
Revenue Next 3Y34.54%
Revenue Next 5Y35.03%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

NICOLET BANKSHARES INC / NCBS FAQ

What is the ChartMill fundamental rating of NICOLET BANKSHARES INC (NCBS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to NCBS.


What is the valuation status for NCBS stock?

ChartMill assigns a valuation rating of 5 / 10 to NICOLET BANKSHARES INC (NCBS). This can be considered as Fairly Valued.


What is the profitability of NCBS stock?

NICOLET BANKSHARES INC (NCBS) has a profitability rating of 1 / 10.


What is the expected EPS growth for NICOLET BANKSHARES INC (NCBS) stock?

The Earnings per Share (EPS) of NICOLET BANKSHARES INC (NCBS) is expected to grow by 32.09% in the next year.


Is the dividend of NICOLET BANKSHARES INC sustainable?

The dividend rating of NICOLET BANKSHARES INC (NCBS) is 0 / 10 and the dividend payout ratio is 0%.